Pyrexia+1
RecruitingStudy on the Safety and Immune Response of the 20-Valent Pneumococcal Vaccine in Adults with Fever and High Risk for Pneumococcal Infection
Study on the Safety and Immune Response of the 20-Valent Pneumococcal Vaccine in Adults with Fever and High Risk for Pneumococcal Infection
- Disease:PyrexiaImmunisation
- Substances:Pneumococcal polysaccharide serotype 15A conjugated to CRM197Pneumococcal polysaccharide serotype 16F conjugated to CRM197+4
France- Participants:18–64 years · 65+ years
- Substances:Pneumococcal polysaccharide serotype 15A conjugated to CRM197
- Sponsor:Centre Hospitalier Universitaire De Saint Etienne

